Biogen (BIIB) Revenue — Quarter Ended Mar 31, 2024
Revenue declined in the current quarter compared with both the prior quarter and the same quarter a year earlier. The sequential decrease was smaller than the year-over-year drop.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue declined in the current quarter compared with both the prior quarter and the same quarter a year earlier. The sequential decrease was smaller than the year-over-year drop.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.3B
Revenue reported for this quarter.
Quarter-over-quarter
-4.0%
Change from the immediately preceding quarter.
Year-over-year
-7.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $2.5B | -5.1% |
| Sep 30, 2023 | $2.5B | +0.9% |
| Dec 31, 2023 | $2.4B | -6.2% |
| Mar 31, 2024 | $2.3B | -7.0% |
Revenue performance
The reported revenue moved lower, continuing a downward trend observed over recent quarters.
Quarterly comparison
Compared with the immediately preceding quarter, revenue was lower. Versus the same quarter one year earlier, revenue also declined, with the year-over-year decrease being more pronounced than the sequential change.
What to watch
Monitor whether the revenue trajectory stabilizes or continues to decline in upcoming quarters.